Strongbridge Biopharma Plc (SBBP) Inventory Turnover Ratio, from second quarter 2021 to second quarter 2020, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Strongbridge Biopharma plc  (NASDAQ: SBBP)
 

Strongbridge Biopharma Plc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Strongbridge Biopharma Plc inventory turnover ratio, the Strongbridge Biopharma Plc's ability to sell and replace its inventory in the second quarter 2021, sequentially increased to 1.6 in the second quarter 2021, SBBP's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Strongbridge Biopharma Plc in Jun 30 2021 quarter, has decreased to 228 days, compare to 250 days, in the Mar 31 2021 quarter.

Within Healthcare sector 289 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2021, to 1427, from total ranking in the first quarter 2021 at 1592.

SBBP Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Strongbridge Biopharma Plc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SBBP Inventory Turnover Ratio (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter
Y / Y Inventory Growth -16.27 % -25.02 % -44.66 % -53.48 % -59.14 %
Y / Y Cost of Sales Growth 18.83 % -57.59 % -55.17 % -59.24 % -61.55 %
Inventory Turnover Ratio (TTM) 1.6 1.46 1.81 1.91 1.9
SBBP's Total Ranking # 1427 # 1592 # 1429 # 1429 # 1355
Average inventory processing period 228 251 201 191 192
Seq. Inventory Growth 9.33 % -8.7 % -1.16 % -15.13 % -2.08 %
Seq. Cost of Sales Growth 13.63 % -7.01 % 8.33 % 3.82 % -59.44 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 90
Healthcare Sector # 290
Overall Market # 1427

Inventory Turnover Ratio Statistics
High Average Low
2.32 1.56 1
(Jun 30 2018)   (Jun 30 2019)



SBBP Company Profile >> Back to SBBP Efficiency Comparisons >> Compare SBBP Inventory Turnover Ratio to its Competitors

Financial Statements
Strongbridge Biopharma Plc's Inventories $ 1 Millions Visit SBBP's Balance sheet
Strongbridge Biopharma Plc's Cost of Revenues TTM $ 2 Millions Visit SBBP's Income Statement
What are SBBP's Sales? Visit SBBP's Sales by Segment

Other Inventory Turnover Ratios
Strongbridge Biopharma Plc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SBBP's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SBBP's Competitors
Inventory Turnover Ratio for SBBP's Suppliers
Inventory Turnover Ratio for SBBP's Customers

You may also want to know
SBBP's Sales Growth Rates SBBP's Pe Price to earnings ratio SBBP's Receivables Turnover Ratio SBBP's Stock Quote
SBBP's Net Income Growth Rates SBBP's Ps Price to Sales ratio SBBP's Sales per Employee SBBP's Asset Turnover Ratio
SBBP's Net Margin SBBP's Pb Price to Book ratio SBBP's Financial Strength Ratios SBBP's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2021, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2021 Inventories at quarter ending Jun 30 2021
Vericel Corporation  4.27 $ 45.561  Millions$ 11  Millions
Escalon Medical Corp   4.25 $ 6.069  Millions$ 1  Millions
Tandem Diabetes Care Inc   4.23 $ 283.234  Millions$ 67  Millions
Glaukos Corp  4.20 $ 71.914  Millions$ 17  Millions
Hill rom Holdings Inc   4.19 $ 1,408.100  Millions$ 336  Millions
Integrated Biopharma Inc  4.18 $ 54.079  Millions$ 13  Millions
Immucell Corporation  4.17 $ 9.095  Millions$ 2  Millions
Caredx Inc   4.13 $ 50.233  Millions$ 12  Millions
Novocure Limited  4.11 $ 111.515  Millions$ 27  Millions
3m Company  4.09 $ 17,935.000  Millions$ 4,381  Millions
Mimedx Group Inc   4.04 $ 43.508  Millions$ 11  Millions
Mallinckrodt Plc  4.02 $ 1,414.500  Millions$ 352  Millions
Fortress Biotech Inc   4.00 $ 19.052  Millions$ 5  Millions
Outset Medical Inc   3.95 $ 82.503  Millions$ 21  Millions
Harrow Inc   3.87 $ 15.820  Millions$ 4  Millions
American Bio Medica Corporation  3.86 $ 2.048  Millions$ 1  Millions
Endo International Plc  3.81 $ 1,341.389  Millions$ 352  Millions
Reflect Scientific Inc  3.80 $ 1.328  Millions$ 0  Millions
Horizon Therapeutics Public Limited Company  3.79 $ 615.127  Millions$ 162  Millions
Cytosorbents Corporation  3.79 $ 10.879  Millions$ 3  Millions
Iridex Corp  3.78 $ 26.209  Millions$ 7  Millions
Pacific Biosciences Of California Inc   3.76 $ 60.630  Millions$ 16  Millions
Teva Pharmaceutical Industries Limited  3.76 $ 8,673.000  Millions$ 2,310  Millions
Dentsply Sirona Inc   3.75 $ 1,878.500  Millions$ 501  Millions
Baxter International Inc   3.72 $ 7,433.000  Millions$ 1,997  Millions
Becton Dickinson And Company  3.70 $ 10,551.000  Millions$ 2,850  Millions
Agilent Technologies inc   3.69 $ 2,847.000  Millions$ 771  Millions
Precision Optics Corporation Inc   3.66 $ 7.241  Millions$ 2  Millions
Sonoma Pharmaceuticals Inc   3.65 $ 10.789  Millions$ 3  Millions
Universal Biosensors Inc   3.65 $ 5.598  Millions$ 2  Millions

Date modified: 2026-08-31T17:15:22+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.